Larson Financial Group »

Nurix Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $29k 1.5k 18.97
2025-09-30 $3.2k 351 9.24
2024-09-30 $538 24 22.46

More positions owned by Larson Financial Group

Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Capital Group Global Equity SHS (CGGE)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Applied Materials (AMAT)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Pgim Etf Tr Active Aggregate (PAB)

View all positions for Larson Financial Group

Top funds holding Nurix Therapeutics

FMR
BlackRock
Deep Track Capital
Vanguard Group
Vestal Point Capital
Baker Bros. Advisors
Redmile Group
State Street Corporation
Pictet Asset Management Holding SA
Point72 Asset Management
Deutsche Bank Aktiengesellschaft
Rubric Capital Management
Geode Capital Management
Commodore Capital
Braidwell

View all funds holding Nurix Therapeutics